Population
Patients with chemotherapy-induced thrombocytopenia and naturally occurring diseases
Design
Review
Authors
Loading...
Extends understanding of thrombopoiesis via endogenous TPO levels; leaves open clinical utility in chemotherapy-induced thrombocytopenia.
This review summarizes the current understanding of endogenous thrombopoietin levels in chemotherapy-induced thrombocytopenia and other diseases.
Janet L. Nichol (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: